Jonathan Marino
Q Chip Limited, a VC-backed pharmaceutical company working on cancer treatments based in the UK, locked in a $6 million Series C fundraising from Dutch investors Limburg Ventures and Nedermaas Hightech Ventures. Prior investors include Disruptive Capital Finance, which to date has led investments totaling $14.2 million in Q Chip Limited; Disruptive Capital also took part in the Series C round.
Cleveland-based private equity firm Primus Capital is selling its Encore Discovery Solutions to a strategic buyer in EPIQ Systems Inc., which is based in Kansas City. Terms of the deal were not disclosed and advisors were not publicized.
Before, investors in private companies had to rely on secondary market exchanges’ accreditation process to accept them in order to start buying into late-stage startups pre-IPO. Before, they were subject to hefty transaction fees if they wanted to jump into shares of startups like Facebook, so that they would have to realize a share value gain just to hit breakeven, if they were short-term buyers. That was before. Michael Moe, one of the founders of GSV Capital Corp., changed that....
Mobile video sharing company Vuclip raised $8 million from a group of investors including New Enterprise Associates and Jafco Ventures. The company has expanded to markets including India, Indonesia and Malaysia. Nick Sturiale of Jafco and Krishna Kolluri of NEA worked on the deal; specifics were not publicized.
Kleiner Perkins Caufield & Byers and Highland Capital Partners teamed to provide mobile app firm session M with a $6.5 million financing. Other partners also contributed to the funding, which session M announced at its website, but they were not publicized. session M will be a part of the KPCB iFund. Bob Davis from Highland and Matt Murphy from KPCB will join the Company's board.
Fifth Street Finance is moving its talent into better roles, and filling out bottom ranks too. Lawrence Beller, Brian Finkelstein & Kyde Sharp were all promoted from Vice President to Directors at Fifth Street Finance Corp., the investment firm announced earlier this week. Fred Chung, an associate, was also hired.
On Sale? 247WallSt.com’s Jon Ogg predicts Gap & Aeropostale will be getting cheaper, something that PE firms would like to see Parting Shots: MassHighTech’s Galen Moore is moving on, and he’s got something to say to your PR department in Boston Now Hiring: UBS takes a new energy banker Going Public: Prada eyes June Hong Kong IPO
Providence Equity Partners’ chief operating officer is no longer with the LBO shop, less than three years into his new role, peHUB has learned. UPDATE: “We appreciate Gary’s contributions to the firm over the last three years, and we wish him well in his future endeavors,” the firm said in a statement e-mailed to peHUB. […]
The Drinks are on Him: Bernie Madoff’s wine collection hits the auction block Snitchin! This one, from Diamondback Big Bucks: Khosla Ventures eyes $1B fund Survey SAYS! LinkedIn is already priced too high!
Secondary direct investment firm Saints Capital is teaming up with Oxford Bioscience Partners and making an investment in a partnership with Oxford that will make follow on investments in six positions initially owned by Oxford. In conjunction with the transaction, Terry Vance, formerly a Managing Director at EGS Healthcare Capital Partners, is joining Saints as a venture partner to manage certain positions in the new partnership.